Suppr超能文献

[小儿骨巨细胞瘤:35例临床病理分析]

[Pediatric giant cell tumor of bone: a clinicopathological analysis of 35 cases].

作者信息

Pang Y R, Zhou J, Chen C Y, Zhao Q Q, Sun K Y, Liu Z Y

机构信息

Department of Pathology, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiaotong University School of Medicine;Comprehensive Oncology Center of Bone and Soft Tissue, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai 200233, China.

出版信息

Zhonghua Bing Li Xue Za Zhi. 2024 Nov 8;53(11):1122-1126. doi: 10.3760/cma.j.cn112151-20240430-00290.

Abstract

To investigate the clinicopathological characteristics of giant cell tumor of bone (GCTB) in children. A total of 35 cases of GCTB diagnosed at Shanghai Sixth People's Hospital Affiliated to Shanghai Jiaotong University School from 2016 to 2023 were collected, and a retrospective analysis of clinicopathological features and imaging findings was conducted. Pediatric GCTB accounted for approximately 4.6% of total GCTB cases during the study period. There were 11 males and 24 females. The onset age ranged from 9 to 18 years (mean age 15 years, median age 16 years), with 8 cases (8/35, 22.9%) experiencing postoperative recurrence. Twenty-eight cases (28/35, 80%) primarily affected long bones, while 7 cases involved small or irregular bones. Imaging revealed osteolytic changes as the predominant feature, with 3 cases exhibited open physis, one of which had the tumor primarily at the diaphysis without crossing the physis. Histologically, pediatric GCTB resembled adult cases, characterized by mononuclear cells and osteoclast-like giant cells. Seven cases with denosumab treatment demonstrated degrees of giant cell disappearance, increased fibrous tissue and reactive bone proliferation in the stroma. One case was diagnosed as pediatric multicentric GCTB, and three cases as pediatric primary malignant GCTB, with malignant transformation into osteosarcoma. In all 35 cases, mutations in the H3F3A gene were identified, comprising 32 cases with H3.3 p.G34W mutations, one case with H3.3 p.G34V mutation, and 2 cases with H3.3 p.G34L mutations. Notably, the former two categories were successfully validated at the protein level through immunohistochemical staining, utilizing highly specific antibodies tailored for these mutation types: H3.3 p.G34W antibody and H3.3 p.G34V antibody. However, immunohistochemical staining was not available for the last category. Pediatric GCTB predominantly affects females and occurs primarily in long bones, mainly around the knee joint, the majority of tumors predominantly arise in the epiphysis and extend into the metaphysis; however, in cases where the epiphyseal plates are still unclosed, the tumors may be restricted to the metaphysis. Detection of H3F3A gene mutation is crucial for the diagnosis and differential diagnosis of pediatric GCTB.

摘要

探讨儿童骨巨细胞瘤(GCTB)的临床病理特征。收集了2016年至2023年在上海交通大学附属第六人民医院确诊的35例GCTB病例,并对其临床病理特征和影像学表现进行回顾性分析。在研究期间,儿童GCTB约占GCTB病例总数的4.6%。其中男性11例,女性24例。发病年龄为9至18岁(平均年龄15岁,中位年龄16岁),8例(8/35,22.9%)术后复发。28例(28/35,80%)主要累及长骨,7例累及小骨或不规则骨。影像学显示以溶骨性改变为主,3例骨骺开放,其中1例肿瘤主要位于骨干,未跨越骨骺。组织学上,儿童GCTB与成人病例相似,以单核细胞和破骨细胞样巨细胞为特征。7例接受地诺单抗治疗的病例显示巨细胞不同程度消失,间质中纤维组织增多和反应性骨增生。1例诊断为儿童多中心GCTB,3例诊断为儿童原发性恶性GCTB,均恶变为骨肉瘤。35例均检测到H3F3A基因突变,其中32例为H3.3 p.G34W突变,1例为H3.3 p.G34V突变,2例为H3.3 p.G34L突变。值得注意的是,前两类通过免疫组化染色在蛋白水平得到成功验证,使用了针对这些突变类型的高度特异性抗体:H3.3 p.G34W抗体和H3.3 p.G34V抗体。然而,最后一类无法进行免疫组化染色。儿童GCTB以女性为主,主要发生于长骨,主要在膝关节周围,大多数肿瘤主要起源于骨骺并延伸至干骺端;然而,在骨骺板仍未闭合的情况下,肿瘤可能局限于干骺端。检测H3F3A基因突变对儿童GCTB的诊断和鉴别诊断至关重要。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验